Cyclerion Therapeutics, Inc.
CYCN
$2.53
$0.062.43%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.81M | 194.00K | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.81M | 194.00K | -- | -- | -- |
| Cost of Revenue | -- | -- | 105.00K | 44.00K | -- |
| Gross Profit | 1.81M | 194.00K | -105.00K | -44.00K | -- |
| SG&A Expenses | 1.25M | 1.24M | 1.28M | 1.57M | 1.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.30M | 1.32M | 1.38M | 1.62M | 1.80M |
| Operating Income | 502.00K | -1.13M | -1.38M | -1.62M | -1.80M |
| Income Before Tax | 530.00K | -723.00K | -1.32M | -1.54M | -1.69M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 530.00K | -723.00K | -1.32M | -1.54M | -1.69M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 0.00 |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 530.00K | -723.00K | -1.32M | -1.54M | -1.69M |
| EBIT | 502.00K | -1.13M | -1.38M | -1.62M | -1.80M |
| EBITDA | -- | -- | -- | -- | -1.78M |
| EPS Basic | 0.21 | -0.29 | -0.53 | -0.62 | -0.70 |
| Normalized Basic EPS | 0.13 | -0.18 | -0.33 | -0.39 | -0.42 |
| EPS Diluted | 0.21 | -0.29 | -0.53 | -0.62 | -0.70 |
| Normalized Diluted EPS | 0.13 | -0.18 | -0.33 | -0.39 | -0.42 |
| Average Basic Shares Outstanding | 2.54M | 2.53M | 2.51M | 2.49M | 2.34M |
| Average Diluted Shares Outstanding | 2.54M | 2.53M | 2.51M | 2.49M | 2.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
